IBBQ – Invesco Nasdaq Biotechnology ETF
Invesco Nasdaq Biotechnology ETF (IBBQ) is a Health ETF, issued by Invesco, $71M in assets, 0.19% expense ratio.
Returns as of Oct 23, 2026: 1 week +2.4%, 1 year +34.9%.
Tracks Nasdaq-compiled index of biotechnology and pharmaceutical companies listed on Nasdaq. Includes large, mid, and small-cap securities.
Top holdings
- VRTX – Vertex Pharmaceuticals Inc, 8.2%
- GILD – Gilead Sciences Inc, 8.0%
- AMGN – Amgen Inc, 7.7%
- REGN – Regeneron Pharmaceuticals Inc, 5.6%
- AZN – AstraZeneca PLC ADR, 4.1%
- ALNY – Alnylam Pharmaceuticals Inc, 3.5%
- INSM – Insmed Inc, 2.6%
- BIIB – Biogen Inc, 1.8%
- RVMD – Revolution Medicines Inc, 1.7%
- ARGX – argenx NV ADR, 1.7%
- ILMN – Illumina Inc, 1.6%
- INCY – Incyte Corporation, 1.5%
- UTHR – United Therapeutics Corporation, 1.5%
- MEDP – Medpace Holdings Inc, 1.3%
- RPRX – Royalty Pharma Plc, 1.3%
- MRNA – Moderna Inc, 1.2%
- ROIV – Roivant Sciences Ltd, 1.2%
- VTRS – Viatris Inc, 1.1%
- BBIO – BridgeBio Pharma Inc, 1.1%
- GH – Guardant Health Inc, 1.1%
- NBIX – Neurocrine Biosciences Inc, 1.0%
- SMMT – Summit Therapeutics PLC, 0.9%
- ASND – Ascendis Pharma AS, 0.9%
- IONS – Ionis Pharmaceuticals Inc, 0.9%
- SNY – Sanofi ADR, 0.9%